3SBio Inc. (HKG:1530)
Hong Kong · Delayed Price · Currency is HKD 19.99
-0.17 (-0.84%)
May 15, 2026, 4:09 PM HKT
3SBio Market Cap
3SBio has a market cap or net worth of 49.99 billion as of May 15, 2026. Its market cap has increased by 65.65% in one year.
Market Cap
49.99B
Enterprise Value
34.70B
Revenue
19.69B
Ranking
n/a
PE Ratio
5.24
Stock Price
19.99
Market Cap Chart
Since June 11, 2015, 3SBio's market cap has increased from 22.67B to 49.99B, an increase of 120.52%. That is a compound annual growth rate of 7.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 49.99B | -17.23% |
| Dec 31, 2025 | 60.39B | 321.75% |
| Dec 31, 2024 | 14.32B | -20.61% |
| Dec 29, 2023 | 18.04B | -10.89% |
| Dec 30, 2022 | 20.24B | 23.46% |
| Dec 31, 2021 | 16.40B | -8.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Akeso | 114.04B |
| Sichuan Kelun-Biotech Biopharmaceutical | 101.39B |
| Sino Biopharmaceutical | 99.75B |
| RemeGen | 65.87B |
| Biocytogen Pharmaceuticals (Beijing) | 43.70B |
| Shanghai Junshi Biosciences | 41.99B |
| Shanghai Henlius Biotech | 37.50B |
| Genscript Biotech | 31.81B |